2024 Q4 Form 10-Q Financial Statement

#000143774924032485 Filed on October 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $12.21M
YoY Change -30.36%
Cost Of Revenue $11.92M
YoY Change 6.34%
Gross Profit $8.083M
YoY Change -170.84%
Gross Profit Margin 66.2%
Selling, General & Admin $432.0K
YoY Change 10.77%
% of Gross Profit 5.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $432.0K
YoY Change 8.0%
Operating Profit $7.651M
YoY Change -164.78%
Interest Expense $7.945M
YoY Change 11.79%
% of Operating Profit 103.84%
Other Income/Expense, Net
YoY Change
Pretax Income $7.651M
YoY Change -164.84%
Income Tax $373.0K
% Of Pretax Income 4.88%
Net Earnings $7.278M
YoY Change -160.75%
Net Earnings / Revenue 59.61%
Basic Earnings Per Share $0.32
Diluted Earnings Per Share $0.20
COMMON SHARES
Basic Shares Outstanding 38.06M 36.06M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $83.38M
YoY Change 76.28%
Cash & Equivalents $86.65M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $99.17M
YoY Change 61.52%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $687.3M
YoY Change -6.1%
Other Assets
YoY Change
Total Long-Term Assets $693.9M
YoY Change -5.7%
TOTAL ASSETS
Total Short-Term Assets $99.17M
Total Long-Term Assets $693.9M
Total Assets $793.1M
YoY Change -0.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $3.072M
YoY Change -0.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $70.28M
YoY Change 6.01%
Total Short-Term Liabilities $86.86M
YoY Change 6.57%
LONG-TERM LIABILITIES
Long-Term Debt $363.7M
YoY Change -1.49%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $363.7M
YoY Change -1.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $86.86M
Total Long-Term Liabilities $363.7M
Total Liabilities $450.5M
YoY Change -0.03%
SHAREHOLDERS EQUITY
Retained Earnings -$157.9M
YoY Change 50.08%
Common Stock $42.00K
YoY Change 20.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $342.5M
YoY Change
Total Liabilities & Shareholders Equity $793.1M
YoY Change -0.52%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $7.278M
YoY Change -160.75%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$28.26M
YoY Change 19.08%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.969M
YoY Change -109.52%
NET CHANGE
Cash From Operating Activities -28.26M
Cash From Investing Activities
Cash From Financing Activities -1.969M
Net Change In Cash -30.23M
YoY Change 891.02%
FREE CASH FLOW
Cash From Operating Activities -$28.26M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
Horizon Technology Finance Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001487428
dei Local Phone Number
LocalPhoneNumber
676‑8654
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
733232000 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
759182000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37970529
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33534854
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37803064
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33367389
CY2024Q3 hrzn Investment Owned Nav Percent
InvestmentOwnedNavPercent
1.997 pure
CY2023Q4 hrzn Investment Owned Nav Percent
InvestmentOwnedNavPercent
2.189 pure
hrzn Investments Nonaccrual Interest Income
InvestmentsNonaccrualInterestIncome
200000 usd
CY2023Q3 hrzn Investments Nonaccrual Interest Income
InvestmentsNonaccrualInterestIncome
0 usd
hrzn Investments Nonaccrual Interest Income
InvestmentsNonaccrualInterestIncome
0 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
us-gaap Open Tax Year
OpenTaxYear
2024 2023 2022 2021
CY2024Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
814-00802
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2114934
dei Entity Address Address Line1
EntityAddressAddressLine1
312 Farmington Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Farmington
dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06032
dei City Area Code
CityAreaCode
860
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38062377
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
684000000 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
709085000 usd
CY2024Q3 us-gaap Cash
Cash
52302000 usd
CY2023Q4 us-gaap Cash
Cash
46630000 usd
CY2024Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
31080000 usd
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
26450000 usd
CY2024Q3 us-gaap Restricted Investments
RestrictedInvestments
3266000 usd
CY2023Q4 us-gaap Restricted Investments
RestrictedInvestments
2642000 usd
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
15789000 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
13926000 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
6637000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
3623000 usd
CY2024Q3 us-gaap Assets
Assets
793074000 usd
CY2023Q4 us-gaap Assets
Assets
802356000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
433969000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
462235000 usd
CY2024Q3 us-gaap Distribution Payable
DistributionPayable
12475000 usd
CY2023Q4 us-gaap Distribution Payable
DistributionPayable
11011000 usd
CY2024Q3 us-gaap Management Fee Payable
ManagementFeePayable
1025000 usd
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
1052000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
3072000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
4077000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
450541000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
478375000 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
36000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
500345000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
450949000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-157854000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127004000 usd
CY2024Q3 hrzn Net Assets
NetAssets
342533000 usd
CY2023Q4 hrzn Net Assets
NetAssets
323981000 usd
CY2024Q3 hrzn Liabilities And Net Assets
LiabilitiesAndNetAssets
793074000 usd
CY2023Q4 hrzn Liabilities And Net Assets
LiabilitiesAndNetAssets
802356000 usd
CY2024Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.06
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.71
CY2024Q3 hrzn Investment Company Investment Income Net
InvestmentCompanyInvestmentIncomeNet
24563000 usd
CY2023Q3 hrzn Investment Company Investment Income Net
InvestmentCompanyInvestmentIncomeNet
29138000 usd
hrzn Investment Company Investment Income Net
InvestmentCompanyInvestmentIncomeNet
76370000 usd
hrzn Investment Company Investment Income Net
InvestmentCompanyInvestmentIncomeNet
85292000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
7945000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
7107000 usd
us-gaap Interest Expense
InterestExpense
24046000 usd
us-gaap Interest Expense
InterestExpense
21407000 usd
CY2024Q3 us-gaap Management Fee Expense
ManagementFeeExpense
2989000 usd
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
3213000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
9178000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
9621000 usd
CY2024Q3 hrzn Performance Based Incentive Fee
PerformanceBasedIncentiveFee
0 usd
CY2023Q3 hrzn Performance Based Incentive Fee
PerformanceBasedIncentiveFee
0 usd
hrzn Performance Based Incentive Fee
PerformanceBasedIncentiveFee
295000 usd
hrzn Performance Based Incentive Fee
PerformanceBasedIncentiveFee
3094000 usd
CY2024Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
400000 usd
CY2023Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
441000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
1259000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
1249000 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
587000 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
452000 usd
us-gaap Professional Fees
ProfessionalFees
1707000 usd
us-gaap Professional Fees
ProfessionalFees
1558000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
432000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
392000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1419000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1384000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
12353000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
11605000 usd
us-gaap Costs And Expenses
CostsAndExpenses
37904000 usd
us-gaap Costs And Expenses
CostsAndExpenses
38313000 usd
CY2024Q3 us-gaap Net Investment Income
NetInvestmentIncome
12210000 usd
CY2023Q3 us-gaap Net Investment Income
NetInvestmentIncome
17533000 usd
us-gaap Net Investment Income
NetInvestmentIncome
38466000 usd
us-gaap Net Investment Income
NetInvestmentIncome
46979000 usd
CY2024Q3 us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
373000 usd
CY2023Q3 us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
179000 usd
us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
1109000 usd
us-gaap Investment Income Operating Tax Expense Benefit
InvestmentIncomeOperatingTaxExpenseBenefit
542000 usd
CY2024Q3 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
11837000 usd
CY2023Q3 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
17354000 usd
us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
37357000 usd
us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
46437000 usd
CY2024Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-33894000 usd
CY2023Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-11816000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-31422000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-28513000 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
29335000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-17518000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
864000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-24448000 usd
CY2024Q3 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-4559000 usd
CY2023Q3 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-29334000 usd
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-30558000 usd
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-52961000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
7278000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-11980000 usd
us-gaap Net Income Loss
NetIncomeLoss
6799000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6524000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.54
CY2024Q3 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
0.2
CY2023Q3 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
-0.37
us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
0.19
us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
-0.22
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.33
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.33
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.04
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.99
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36571000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32451900
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35200189
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30155287
CY2023Q2 us-gaap Assets Net
AssetsNet
355419000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13855000 usd
CY2023Q3 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
17354000 usd
CY2023Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-11816000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-17518000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
307000 usd
CY2023Q3 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
11026000 usd
CY2023Q3 us-gaap Assets Net
AssetsNet
346575000 usd
CY2024Q2 us-gaap Assets Net
AssetsNet
328778000 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18415000 usd
CY2024Q3 us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
11837000 usd
CY2024Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-33894000 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
29335000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
583000 usd
CY2024Q3 us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
12521000 usd
CY2024Q3 us-gaap Assets Net
AssetsNet
342533000 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
318448000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
65031000 usd
us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
46437000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-28513000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-24448000 usd
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
776000 usd
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
31156000 usd
CY2023Q3 us-gaap Assets Net
AssetsNet
346575000 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
323981000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47527000 usd
us-gaap Investment Income Operating After Expense And Tax
InvestmentIncomeOperatingAfterExpenseAndTax
37357000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-31422000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
864000 usd
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
1875000 usd
us-gaap Investment Company Dividend Distribution
InvestmentCompanyDividendDistribution
37649000 usd
CY2024Q3 us-gaap Assets Net
AssetsNet
342533000 usd
us-gaap Net Income Loss
NetIncomeLoss
6799000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6524000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1272000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1433000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-31422000 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-28513000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
864000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-24448000 usd
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
121211000 usd
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
154488000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Securities Operating Activities
ProceedsFromMaturitiesPrepaymentsAndCallsOfSecuritiesOperatingActivities
120448000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Securities Operating Activities
ProceedsFromMaturitiesPrepaymentsAndCallsOfSecuritiesOperatingActivities
90222000 usd
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
2114000 usd
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
6088000 usd
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
157000 usd
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
11063000 usd
hrzn Equity Received In Settlement Of Fee Income
EquityReceivedInSettlementOfFeeIncome
0 usd
hrzn Equity Received In Settlement Of Fee Income
EquityReceivedInSettlementOfFeeIncome
-89000 usd
hrzn Warrants Received In Settlement Of Fee Income
WarrantsReceivedInSettlementOfFeeIncome
-359000 usd
hrzn Warrants Received In Settlement Of Fee Income
WarrantsReceivedInSettlementOfFeeIncome
-80000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
775000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-1491000 usd
hrzn Increase Decrease In Endofterm Payments
IncreaseDecreaseInEndoftermPayments
1088000 usd
hrzn Increase Decrease In Endofterm Payments
IncreaseDecreaseInEndoftermPayments
1960000 usd
hrzn Increase Decrease In Unearned Income
IncreaseDecreaseInUnearnedIncome
2381000 usd
hrzn Increase Decrease In Unearned Income
IncreaseDecreaseInUnearnedIncome
2621000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
201000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
837000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1005000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
414000 usd
us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
-27000 usd
us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
15000 usd
us-gaap Increase Decrease In Incentive Fee Payable
IncreaseDecreaseInIncentiveFeePayable
0 usd
us-gaap Increase Decrease In Incentive Fee Payable
IncreaseDecreaseInIncentiveFeePayable
-1392000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30073000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16480000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47527000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
65031000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
50000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
59250000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
70000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
35000000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3334000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
732000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
34310000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
28548000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19147000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36125000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10926000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19645000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
75722000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30466000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86648000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
50111000 usd
us-gaap Interest Paid Net
InterestPaidNet
22770000 usd
us-gaap Interest Paid Net
InterestPaidNet
19956000 usd
hrzn Refinanced Debt Investment Balances
RefinancedDebtInvestmentBalances
19540000 usd
hrzn Refinanced Debt Investment Balances
RefinancedDebtInvestmentBalances
0 usd
hrzn Warrant Investments Received And Recorded As Unearned Income
WarrantInvestmentsReceivedAndRecordedAsUnearnedIncome
1269000 usd
hrzn Warrant Investments Received And Recorded As Unearned Income
WarrantInvestmentsReceivedAndRecordedAsUnearnedIncome
1870000 usd
CY2024Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
12475000 usd
CY2023Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
10991000 usd
hrzn Endofterm Payments Receivable Noncash Transaction
EndoftermPaymentsReceivableNoncashTransaction
12905000 usd
hrzn Endofterm Payments Receivable Noncash Transaction
EndoftermPaymentsReceivableNoncashTransaction
11743000 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
9448000 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
12861000 usd
CY2024Q3 us-gaap Cash
Cash
52302000 usd
CY2023Q3 us-gaap Cash
Cash
34816000 usd
CY2024Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
31080000 usd
CY2023Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
12457000 usd
CY2024Q3 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
3266000 usd
CY2023Q3 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
2838000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86648000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50111000 usd
CY2024Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
733232000 usd
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
684000000 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
759182000 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
709085000 usd
CY2023Q4 hrzn Percentage Of Nonqualifying Assets On A Cost Basis
PercentageOfNonqualifyingAssetsOnACostBasis
0.047 pure
CY2023Q4 hrzn Percentage Of Nonqualifying Assets On A Fair Value Basis
PercentageOfNonqualifyingAssetsOnAFairValueBasis
0.027 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 11pt;"><b><i>Use of estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">In preparing the consolidated financial statements in accordance with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the balance sheet and income and expenses for the period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the valuation of investments.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q3 hrzn Investments Nonaccrual Interest Income
InvestmentsNonaccrualInterestIncome
200000 usd
CY2024Q3 hrzn Investment Income Attributable To Noncash Paidinkind Interest Percent
InvestmentIncomeAttributableToNoncashPaidinkindInterestPercent
0.015 pure
CY2023Q3 hrzn Investment Income Attributable To Noncash Paidinkind Interest Percent
InvestmentIncomeAttributableToNoncashPaidinkindInterestPercent
0.135 pure
hrzn Investment Income Attributable To Noncash Paidinkind Interest Percent
InvestmentIncomeAttributableToNoncashPaidinkindInterestPercent
0.028 pure
hrzn Investment Income Attributable To Noncash Paidinkind Interest Percent
InvestmentIncomeAttributableToNoncashPaidinkindInterestPercent
0.071 pure
CY2024Q3 hrzn Investment Nonaccrual Income Not Received In Cash Percent
InvestmentNonaccrualIncomeNotReceivedInCashPercent
0.046 pure
CY2023Q3 hrzn Investment Nonaccrual Income Not Received In Cash Percent
InvestmentNonaccrualIncomeNotReceivedInCashPercent
0.051 pure
hrzn Investment Nonaccrual Income Not Received In Cash Percent
InvestmentNonaccrualIncomeNotReceivedInCashPercent
0.06 pure
hrzn Investment Nonaccrual Income Not Received In Cash Percent
InvestmentNonaccrualIncomeNotReceivedInCashPercent
0.049 pure
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7900000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5800000 usd
CY2024Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
6700000 usd
CY2023Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
5200000 usd
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
500000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
500000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1300000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1400000 usd
CY2024Q3 hrzn Federal Excise Tax Percent
FederalExciseTaxPercent
0.04 pure
CY2024Q3 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
400000 usd
CY2023Q3 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
200000 usd
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
1100000 usd
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
500000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2024Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
167465
hrzn Stock Repurchased During Period Per Share
StockRepurchasedDuringPeriodPerShare
11.22
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1900000 usd
CY2024Q3 us-gaap Management Fee Expense
ManagementFeeExpense
3000000 usd
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
3200000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
9200000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
9600000 usd
CY2024Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
733232000 usd
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
684000000 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
759182000 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
709085000 usd
CY2024Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
733232000 usd
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
684000000 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
759182000 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
709085000 usd
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
646232000 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
85827000 usd
CY2024Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived
411000 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
44392000 usd
CY2024Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest
377000 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
69000 usd
CY2024Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings
-33894000 usd
CY2024Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings
28974000 usd
CY2024Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments
0 usd
CY2024Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease
-456000 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
683010000 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
713244000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
66935000 usd
CY2023Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived
1294000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
25726000 usd
CY2023Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest
3934000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
2557000 usd
CY2023Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings
-11552000 usd
CY2023Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings
-20722000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
-5000000 usd
CY2023Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments
0 usd
CY2023Q3 hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease
-715000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
719135000 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
706858000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
121211000 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived
1628000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
120448000 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest
2114000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
157000 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings
-31213000 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings
1906000 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments
0 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease
1111000 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
683010000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
716319000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
154488000 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Warrants And Equity Received
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetWarrantsAndEquityReceived
2039000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
90222000 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Payment Inkind Interest
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaymentInkindInterest
6088000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
11063000 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Realized Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings
-28198000 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Appreciation Depreciation Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAppreciationDepreciationIncludedInEarnings
-26384000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
-5111000 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Between Investments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersBetweenInvestments
0 usd
hrzn Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Other Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetOtherPeriodIncreaseDecrease
1179000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
719135000 usd
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
705970000 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
436970000 usd
CY2024Q3 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
269000000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
615000000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
466000000 usd
CY2023Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
149000000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
3001000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
3765000 usd
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
705970000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
433969000 usd
CY2024Q3 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
269000000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
615000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
462235000 usd
CY2023Q4 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
149000000 usd
CY2024Q3 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
189875000 usd
CY2024Q3 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
1772000 usd
CY2023Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
180500000 usd
CY2023Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
2033000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.04
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
27827000 usd
us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
126380
us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
1451000 usd
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.37
CY2023 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
41881000 usd
CY2023 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
145743
CY2023 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
1833000 usd
CY2024Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.33
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2024Q3 us-gaap Earnings Per Share Basic Undistributed
EarningsPerShareBasicUndistributed
1.27
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.71
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
11.47
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.06
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.54
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.89
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.95
hrzn Investment Company Investment Depreciation Appreciation Per Share
InvestmentCompanyInvestmentDepreciationAppreciationPerShare
0.02
hrzn Investment Company Investment Depreciation Appreciation Per Share
InvestmentCompanyInvestmentDepreciationAppreciationPerShare
-0.81
us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
0.19
us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
-0.22
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.04
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.99
hrzn Investment Company Distribution To Shareholders Per Share Net Investment Income
InvestmentCompanyDistributionToShareholdersPerShareNetInvestmentIncome
-1.04
hrzn Investment Company Distribution To Shareholders Per Share Net Investment Income
InvestmentCompanyDistributionToShareholdersPerShareNetInvestmentIncome
-0.99
CY2024Q3 hrzn Investment Company Distribution To Shareholders Per Share Net Realized Gain On Investments
InvestmentCompanyDistributionToShareholdersPerShareNetRealizedGainOnInvestments
0
CY2023Q3 hrzn Investment Company Distribution To Shareholders Per Share Net Realized Gain On Investments
InvestmentCompanyDistributionToShareholdersPerShareNetRealizedGainOnInvestments
0
us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
0
us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
0
hrzn Investment Company Distribution To Shareholders Per Share Other
InvestmentCompanyDistributionToShareholdersPerShareOther
0.2
hrzn Investment Company Distribution To Shareholders Per Share Other
InvestmentCompanyDistributionToShareholdersPerShareOther
0.15
CY2024Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.06
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
10.41
CY2023Q4 us-gaap Share Price
SharePrice
13.17
CY2022Q4 us-gaap Share Price
SharePrice
11.6
CY2024Q3 us-gaap Share Price
SharePrice
10.65
CY2023Q3 us-gaap Share Price
SharePrice
11.88
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.112 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.109 pure
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37803064
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33306958
us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.151 pure
us-gaap Investment Company Expense Ratio Excluding Incentive Fee
InvestmentCompanyExpenseRatioExcludingIncentiveFee
0.14 pure
us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.001 pure
us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.012 pure
us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.152 pure
us-gaap Investment Company Expense Ratio Including Incentive Fee
InvestmentCompanyExpenseRatioIncludingIncentiveFee
0.152 pure
us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.15 pure
us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.185 pure
CY2024Q3 hrzn Net Assets
NetAssets
342533000 usd
CY2023Q3 hrzn Net Assets
NetAssets
346575000 usd
CY2024Q3 hrzn Average Net Assets
AverageNetAssets
331853000 usd
CY2023Q3 hrzn Average Net Assets
AverageNetAssets
335531000 usd
hrzn Investment Company Average Debt Per Share
InvestmentCompanyAverageDebtPerShare
12.7
hrzn Investment Company Average Debt Per Share
InvestmentCompanyAverageDebtPerShare
14.29
hrzn Investment Company Portfolio Turnover Ratio
InvestmentCompanyPortfolioTurnoverRatio
0.134 pure
hrzn Investment Company Portfolio Turnover Ratio
InvestmentCompanyPortfolioTurnoverRatio
0.10 pure

Files In Submission

Name View Source Status
0001437749-24-032485-index-headers.html Edgar Link pending
0001437749-24-032485-index.html Edgar Link pending
0001437749-24-032485.txt Edgar Link pending
0001437749-24-032485-xbrl.zip Edgar Link pending
ex_716118.htm Edgar Link pending
ex_716119.htm Edgar Link pending
ex_716120.htm Edgar Link pending
ex_716121.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hrzn-20240930.xsd Edgar Link pending
hrzn20240930_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hrzn-20240930_cal.xml Edgar Link unprocessable
hrzn-20240930_def.xml Edgar Link unprocessable
hrzn-20240930_lab.xml Edgar Link unprocessable
hrzn-20240930_pre.xml Edgar Link unprocessable
hrzn20240930_10q_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending